Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P00520 (ABL1_MOUSE) Mus musculus (Mouse)

Tyrosine-protein kinase ABL1 UniProtKBInterProSTRINGInteractive Modelling

1123 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE Heteromer
P55194;
64-121
SO4;
Assess
Structure, thermodynamics, and the role of conformational dynamics in the interactions between the … Heteromer
Q64010;
757-765
PEG;NA;
Assess
CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAINhomo-2-mer65-120
Assess
Structural basis for the auto-inhibition of c-Abl tyrosine kinasemonomer64-512
MYR;P16;GOL;
Assess
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine tem…monomer229-514
B90;
Assess
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant a…monomer229-513
0LI;
Assess
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine tem…monomer229-511
B91;
Assess
Crystal Structure of the T315I Mutant of Abl kinase bound with PPY-Amonomer229-511
P3Y;
Assess
Crystal structure of ABL T315I mutant kinase domain bound with a DFG-out inhibitor AP24589monomer229-511
XY3;
Assess
Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534monomer229-511
0LI;
Assess
Structure of Abl kinase in complex with imatinib and GNF-2monomer229-510
STJ;STI;CL;
Assess
Structural basis for the auto-inhibition of c-Abl tyrosine kinasemonomer229-510
CL;MYR;STI;
Assess
ABL1 IN COMPLEX WITH COMPOUND 7 AND IMATINIB (STI-571)monomer229-510
GOL;CL;FYW;STI;
Assess
ABL1 IN COMPLEX WITH COMPOUND6 AND IMATINIB (STI-571)monomer229-510
CL;FYH;STI;
Assess
Abl kinase domain in complex with NVP-AFG210monomer229-502
KIN;
Assess
Crystal Structure of Abl kinase bound with PPY-Amonomer229-501
P3Y;
Assess
CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITORmonomer229-499
PRC;
Assess
Crystal Structure of the c-Abl Kinase domain in complex with PD173955monomer232-502
P17;
Assess
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
SX7;
Assess
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
SX7;
Assess
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
SX7;
Assess
CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.monomer229-498
CL;STI;
Assess
ABL kinase in complex with imatinib and a fragment (FRAG1) in the myristate pocketmonomer230-498
STI;MS9;CL;
Assess
Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate sitemonomer232-498
STI;MS7;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1opk.1.Amonomer0.8064-512
MYR;P16;99.80
Assess
1opl.2.Amonomer0.78121-499
P16;98.97
Assess
1zzp.1.Amonomer0.781017-1123
95.97
Assess
1y57.1.Amonomer0.7164-500
43.39
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21opk.1.Amonomer0.8058-505
MYR;P16;99.79
Assess
Isoform 21opl.2.Amonomer0.78115-493
P16;98.57
Assess
Isoform 21zzp.1.Amonomer0.781011-1117
95.97
Assess
Isoform 21y57.1.Amonomer0.7158-494
43.39
Assess
Isoform 31opk.1.Amonomer0.8159-507
MYR;P16;99.80
Assess
Isoform 31opl.2.Amonomer0.79116-494
P16;98.77
Assess
Isoform 31zzp.1.Amonomer0.781012-1118
95.97
Assess
Isoform 31y57.1.Amonomer0.7159-495
43.39
Assess
Isoform 41opl.1.Amonomer0.8181-531
MYR;P16;99.44
Assess
Isoform 41opl.2.Amonomer0.79140-518
P16;99.43
Assess
Isoform 41zzp.1.Amonomer0.781036-1142
95.97
Assess
Isoform 41y57.1.Amonomer0.7183-519
43.39
Assess